Literature DB >> 26571081

Modeling and Treatment of Radiation Cystitis.

Bernadette M M Zwaans1, Michael B Chancellor2, Laura E Lamb3.   

Abstract

Radiation cystitis (RC) is a debilitating condition that, if not managed at an early stage, can have a major impact on the quality of life of a patient and can lead to severe hemorrhaging and even death. Current treatments are focused on arresting bladder hemorrhaging, but none are able to relieve other urological symptoms associated with cystitis. There is a strong need for in-depth studies using preclinical RC models to better understand the underlying disease progression and to test novel therapies. Here we review the most commonly used therapies for RC, novel treatment strategies, and the preclinical models used to date.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26571081     DOI: 10.1016/j.urology.2015.11.001

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

Review 1.  [Radiation cystitis : Pathophysiology and treatment].

Authors:  S Mühlstädt; N Mohammed; K Weigand; A Schumann; F Kawan; C Göllert; P Fornara
Journal:  Urologe A       Date:  2017-03       Impact factor: 0.639

Review 2.  Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies.

Authors:  Bernadette M M Zwaans; Laura E Lamb; Sarah Bartolone; Heinz E Nicolai; Michael B Chancellor; Stangel-Wójcikiewicz Klaudia
Journal:  Int Urol Nephrol       Date:  2018-08-21       Impact factor: 2.370

3.  Studies of ultrastructure, gene expression, and marker analysis reveal that mouse bladder PDGFRA+ interstitial cells are fibroblasts.

Authors:  Dennis R Clayton; Wily G Ruiz; Marianela G Dalghi; Nicolas Montalbetti; Marcelo D Carattino; Gerard Apodaca
Journal:  Am J Physiol Renal Physiol       Date:  2022-07-14

4.  Inhibition of hypoxia-inducible factor-prolyl hydroxylation protects from cyclophosphamide-induced bladder injury and urinary dysfunction.

Authors:  Douglass B Clayton; Ching Man Carmen Tong; Belinda Li; Abby S Taylor; Shuvro De; Matthew D Mason; Anne G Dudley; Olena Davidoff; Hanako Kobayashi; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2022-05-02

5.  Dual effects of radiation bystander signaling in urothelial cancer: purinergic-activation of apoptosis attenuates survival of urothelial cancer and normal urothelial cells.

Authors:  Malgorzata A Bill; Kirtiman Srivastava; Conor Breen; Karl T Butterworth; Stephen J McMahon; Kevin M Prise; Karen D McCloskey
Journal:  Oncotarget       Date:  2017-10-24

6.  Modeling of chronic radiation-induced cystitis in mice.

Authors:  Bernadette M M Zwaans; Sarah Krueger; Sarah N Bartolone; Michael B Chancellor; Brian Marples; Laura E Lamb
Journal:  Adv Radiat Oncol       Date:  2016-08-01

7.  Radiation cystitis modeling: A comparative study of bladder fibrosis radio-sensitivity in C57BL/6, C3H, and BALB/c mice.

Authors:  Bernadette M M Zwaans; Kyle A Wegner; Sarah N Bartolone; Chad M Vezina; Michael B Chancellor; Laura E Lamb
Journal:  Physiol Rep       Date:  2020-02

8.  De novo OAB After ATOMS: An Underestimated Problem or a Rare Side Effect?

Authors:  Sandra Schönburg; Wilhelm Bauer; Nasreldin Mohammed; Clemens Brössner; Paolo Fornara
Journal:  Front Surg       Date:  2019-12-17

9.  A non-invasive ultrasound imaging method to measure acute radiation-induced bladder wall thickening in rats.

Authors:  Antonello E Spinelli; Andrea Bresolin; Stefania Zuppone; Laura Perani; Giuseppe Fallara; Nadia Di Muzio; Riccardo Vago; Claudio Fiorino; Cesare Cozzarini
Journal:  Radiat Oncol       Date:  2020-10-17       Impact factor: 3.481

Review 10.  Pre-clinical Research on Bladder Toxicity After Radiotherapy for Pelvic Cancers: State-of-the Art and Challenges.

Authors:  Stefania Zuppone; Andrea Bresolin; Antonello E Spinelli; Giuseppe Fallara; Roberta Lucianò; Federico Scarfò; Fabio Benigni; Nadia Di Muzio; Claudio Fiorino; Alberto Briganti; Andrea Salonia; Francesco Montorsi; Riccardo Vago; Cesare Cozzarini
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.